This is not the most recent version of the article. View current version (6 FEB 2014)

Overview of Reviews Protocol

Safety of regular formoterol or salmeterol in adults with asthma: an overview of Cochrane reviews

  1. Christopher J Cates1,*,
  2. L. Susan Wieland2,
  3. Marta Oleszczuk3

Editorial Group: Cochrane Airways Group

Published Online: 31 JAN 2013

DOI: 10.1002/14651858.CD010314


How to Cite

Cates CJ, Wieland LS, Oleszczuk M. Safety of regular formoterol or salmeterol in adults with asthma: an overview of Cochrane reviews (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 1. Art. No.: CD010314. DOI: 10.1002/14651858.CD010314.

Author Information

  1. 1

    St George's, University of London, Population Health Sciences and Education, London, UK

  2. 2

    University of Maryland School of Medicine, Center for Integrative Medicine, Baltimore, Maryland, USA

  3. 3

    University of Alberta, Alberta Research Centre for Health Evidence, Edmonton, AB, Canada

*Christopher J Cates, Population Health Sciences and Education, St George's, University of London, Cranmer Terrace, London, SW17 0RE, UK. ccates@sgul.ac.uk.

Publication History

  1. Publication Status: New
  2. Published Online: 31 JAN 2013

SEARCH

This is not the most recent version of the article. View current version (06 FEB 2014)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To assess the risk of serious adverse events in adults treated with regular maintenance formoterol or salmeterol compared to placebo, or if used in combination with regular ICS, compared to the same dose of ICS.